After completing a Bachelor of Pharmaceutical Sciences, Negin started her career at Nucleus Network where she gained an in-depth and hands-on understanding of early phase clinical trials.
Negin advanced her career working across a broad range of therapeutic areas from monitoring and management of clinical trials to leading national product launches for pharmaceutical companies and CROs.
Undertaking an MBA provided her with the knowledge and skills of good management and strategic planning for her clients.
In devoting her career towards understanding innovation and change within the industry, Negin decided to apply her experience and expertise in helping research services understand the gaps and opportunities in the industry.
She built CPC as an Australian CRO, specialising in early phase trials that can provide a much-needed, holistic approach to short and long-term solutions.
Patrick has extensive experience in the fields of drug discovery and development. This includes five years as a postdoctoral researcher in the United States and over five years as a senior pharmacology scientist in China. Patrick has strong expertise in the fields of pharmacology research, drug discovery, in-vivo pharmacodynamics, preclinical development, and IND regulatory file preparation.
Working closely with Negin and using his US and China networks, Patrick is helping dynamic Chinese pharmaceutical clients link to Australia’s clinical trial framework; expanding business opportunities and bridging international links across the Asia-Pacific region.
Utilising his expertise in these fields, Patrick has contributed to 21 high-quality research publications and multiple first-in class INDs.
Amy is a highly-motivated professional with over 10 years of experience in the pharmaceutical industry across quality management, audit preparation, and protocol training and education for clients.
With a strong passion for driving research-based outcomes in the pharmaceutical industry, Amy excels in providing tailored services to meet her clients' needs.